Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Pediatrics

• Publication date

  1990-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 2304786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine.

  1989cited by this paper
• Immunization after invasive Haemophilus influenzae type b disease. Serologic response to a conjugate vaccine.

  1989cited by this paper
• Prospects for overcoming maturational and genetic barriers to the human antibody response to the capsular polysaccharide of Haemophilus influenzae type b.

  1988cited by this paper
• IgG subclass distribution of antibody induced by immunization with the isolated and protein-conjugated polysaccharide of H. influenzae b and G2m(n) distribution of serum IgG2 in man.

  1988cited by this paper
• Comparison of active and combined passive/ active immunization of Navajo children against Haemophilus influenzae type b

  1988cited by this paper
• Epidemiology of Haemophilus influenzae type b infections in the United States.

  1987cited by this paper
• Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b

  1987cited by this paper
• Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine.

  1986cited by this paper
• Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.

  1985cited by this paper
• Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study.

  1985cited by this paper
• The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.

  1983cited by this paper
• Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

  1981cited by this paper
• Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

  1980cited by this paper
• Systemic Haemophilus influenzae disease: an overview.

  1979cited by this paper
• Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B.

  1978cited by this paper
• Demographic factors in the epidemiology of hemophilus influenzae meningitis in young children.

  1978cited by this paper
• Bacterial meningitis in Navojo Indians.

  1976cited by this paper
• Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.

  1971cited by this paper

• Analysis of immunogenicity and purification methods in conjugated polysaccharide vaccines: a new approach in fighting pathogenic bacteria

  2024cites this paper
• Adverse outcome detection of childhood administered thimerosal-free HibTITER®

  2024cites this paper
• Comparison of pneumococcal conjugate vaccine (PCV-13) cellular immune responses after primary and booster doses of vaccine

  2020cites this paper
• Coronaviruses' sugar shields as vaccine candidates.

  2020cites this paper
• Comparative Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae Type b Vaccine for the Prevention Acute Otitis Media with Tympanic Membrane Perforation: A Secondary Analysis of Data from a Randomized Trial among Bangladeshi Infants

  2015cites this paper
• Haemophilus b Conjugate Vaccines for Prevention of Haemophilus influenzae Type b Disease Among Infants and Children Two Months of Age and Older Recommendations of the ACIP

  2015cites this paper
• B-cell development and pneumococcal immunity in vertically acquired HIV infection

  2014cites this paper
• The Evolution of a Glycoconjugate Vaccine for Candida albicans

  2014cites this paper
• The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?

  2013cites this paper
• Variable Region Expression in the Antibody Responses of Infants Vaccinated with Haemophilus influenzae Type b Polysaccharide-Protein Conjugates Description of a New X Light Chain-associated Idiotype and the Relation between Idiotype Expression , Avidity , and Vaccine Formulation

  2013cites this paper
• Epiglottitis in a Vaccinated Child: A Lifesaving Diagnosis

  2012cites this paper
• Cancer vaccines and carbohydrate epitopes.

  2011cites this paper
• Immunologic and clinical features of 25 Amish patients with RMRP 70 A-->G cartilage hair hypoplasia.

  2009cites this paper
• Active Immunization of Premature and Low Birth-Weight Infants

  2007cites this paper
• Development and characterization of the immune response induced by peptides and DNA constructs that mimic the capsular polysaccharide of Neisseria meningitidis serogroup C

  2005cites this paper
• Respiratory Bacterial Vaccines

  2005cites this paper
• Content and dynamics of the human antibody variable region repertoire to the Haemophilus influenzae type b polysaccharide

  2004cites this paper
• Evaluation of the continuing effectiveness of the United Kingdom's Haemophilus influenzae type b national immunisation programme

  2004cites this paper
• Maternal immunization: the influence of liability issues on vaccine development.

  2001cites this paper
• A MULTI-LABORATORY EVALUATION OF AN ENZYME-LINKED IMMUNOASSAY QUANTITATING HUMAN ANTIBODIES TO STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES

  2001cites this paper
• Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 years.

  2000cites this paper
• Timing of Vaccinations in Premature Infants

  2000cites this paper
• The Ability of B Cells and Dendritic Cells to Present Antigen Increases During Ontogeny

  2000cites this paper
• Follow-up of Saudi children vaccinated with Haemophilus influenzae type B vaccine.

  2000cites this paper
• Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates.

  1999cites this paper
• Conjugate Vaccines for Streptococcus pneumoniae

  1999cites this paper
• A routine high-performance size-exclusion chromatography to determine molecular size distribution of Haemophilus influenzae type b conjugate vaccines.

  1999cites this paper
• Characterization of hgpA, a gene encoding a haemoglobin/haemoglobin-haptoglobin-binding protein of Haemophilus influenzae.

  1999cites this paper
• Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines.

  1999cites this paper
• Three-year Follow-up of Vaccine Response in Extremely Preterm Infants

  1998cites this paper
• Acute epiglottis.

  1998cites this paper
• Immunoassay of human Neisseria meningitidis serogroup A antibody.

  1998cites this paper
• Immunization for Haemophilus influenzae type b: Effects on mortality and morbidity in children under five years of age

  1998cites this paper
• Murine Immune Responses to Neisseria meningitidis Group C Capsular Polysaccharide and a Thymus-Dependent Toxoid Conjugate Vaccine

  1998cites this paper
• Early immunization with conjugate vaccines.

  1998cites this paper
• Application of cystamine and N,N'-Bis(glycyl)cystamine as linkers in polysaccharide-protein conjugation.

  1998cites this paper
• Immunogenicity of Haemophilus influenzae‐diphtheria CRM197 protein conjugate vaccine (HbOC) in Libyan infants

  1998cites this paper
• Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.

  1998cites this paper
• Transcription of genes encoding iron and heme acquisition proteins of Haemophilus influenzae during acute otitis media

  1997cites this paper
• Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.

  1997cites this paper
• Immunoassay of human Neisseria meningitidis serogroup A antibody.

  1997cites this paper
• Glycoconjugate vaccines: future combinations.

  1996cites this paper
• Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.

  1996cites this paper
• Antibody response to unconjugated Haemophilus influenzae b and pneumococcal polysaccharide vaccines in children with recurrent infections.

  1996cites this paper
• Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.

  1996cites this paper
• A hospital outbreak of multiresistant haemophilus influenzae type B.

  1996cites this paper
• Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.

  1996cites this paper
• Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.

  1996cites this paper
• Cloning of a DNA fragment encoding a heme-repressible hemoglobin-binding outer membrane protein from Haemophilus influenzae

  1996cites this paper
• T cell-independent antigens type 2.

  1995cites this paper
• Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations.

  1995cites this paper
• Epidemiology and prevention of meningococcal disease

  1995cites this paper
• Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.

  1995cites this paper
• Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines.

  1995cites this paper
• Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines.

  1995cites this paper
• Conjugate Hib Vaccines and their Combinations: Present Success and Future Possibilities

  1995cites this paper
• Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.

  1995cites this paper
• Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.

  1994cites this paper
• Glycoconjugate Vaccines: What Next?

  1994cites this paper
• Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. The Collaborati

  1993cites this paper
• Antibody response of Navajo children primed with PRP‐OMP vaccine to booster doses of PRP‐OMP vs. HbOC vaccine

  1993cites this paper
• Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.

  1993cites this paper
• Characterization of the serum antibody response induced by Haemophilus influenzae type b tetanus protein-conjugate vaccine in infants receiving a DTP-combined vaccine from 2 months of age.

  1993cites this paper
• Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide‐CRM197 (HbOC) conjugate vaccine

  1993cites this paper
• Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.

  1993cites this paper
• Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants

  1993cites this paper
• Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.

  1993cites this paper
• Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. V. In vivo expression of individual antibody clones is dependent on Ig CH haplotypes and the categories of antigen.

  1993cites this paper
• Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.

  1993cites this paper
• Clinical coding: completeness and accuracy when doctors take it on.

  1993cites this paper
• Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.

  1993cites this paper
• The Pharmacist Practitioner’s Role in Biotechnology: Clinical Application of Biotechnology Products

  1993cites this paper
• Vaccination against Haemophilus influenzae b disease.

  1992cites this paper
• Haemophilus b conjugate vaccines.

  1992cites this paper
• A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.

  1992cites this paper
• Correlation between antibody affinity and serum bactericidal activity in infants.

  1992cites this paper
• Thymus-independent and thymus-dependent responses to polysaccharide antigens.

  1992cites this paper
• IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants.

  1992cites this paper
• Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.

  1992cites this paper
• [Anti-Haemophilus b vaccine].

  1992cites this paper
• Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use.

  1992cites this paper
• Effect of phosphate ester residues on the immunogenicity of CRM197-coupled Haemophilus influenzae type b capsular saccharides in 2-month-old infants.

  1992cites this paper
• Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.

  1992cites this paper
• Haemophilus Influenzae Type B Conjugate Vaccines

  1992cites this paper
• Decline of Haemophilus disease in Cleveland.

  1992cites this paper
• Immunogenicity ofHaemophilus influenzae type b capsular polysaccharide and its tetanus toxoid conjugate in patients with recurrent infections or humoral immunodeficiency

  1992cites this paper
• Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies

  1992cites this paper
• High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.

  1992cites this paper
• Immune response to Hib conjugate vaccine.

  1992cites this paper
• The biology of Haemophilus influenzae type b vaccination failure.

  1992cites this paper
• Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy

  1991cites this paper
• Antibody persistence four years after primary immunization of infants and toddlers with Haemophilus influenzae type b CRM197 conjugate vaccine.

  1991cites this paper
• Prospective comparison of the immune response of infants to three Haemophilus influenzae type b vaccines

  1991cites this paper
• Age of initiation of Haemophilus b immunization.

  1991cites this paper
• Augmentation by interleukins of the antibody response to a conjugate vaccine against Haemophilus influenzae b.

  1991cites this paper
• Haemophilus influenzae disease and immunization in developing countries.

  1991cites this paper
• Prevention of invasive Haemophilus influenzae type b disease: lessons from vaccine efficacy trials.

  1991cites this paper
• Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.

  1991cites this paper
• Immunizations.

  1991cites this paper
• Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.

  1991cites this paper